A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Clinical trial NCT05141721 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05141721
- Sponsor
- Seattle Project Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-12
- Primary completion
- 2027-03-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.